Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 27
Health Canada Reports Remicade May Cause Rare, Aggressive Cancer
California Jurors Find for Merck in State's First Vioxx Trial
Judge Denies Merck Motion to Quash Subpoena for Vioxx MDL Trial
N.J. Supreme Court to Hear Appeal of National Vioxx Class Certification
Court Reverses Venue Ruling, Orders Transfer of Vioxx Class Action
Merck Seeks to Bifurcate Damage Phases for Second Federal Vioxx Trial
Arthritis Drugs - Issue: 26
Arthritis Drugs in the Medical Literature This Month - July 2006
Arthritis Drugs - Issue: 27
Survey: Patients Wary of Seeking Pain Relief Due to Drug Safety Concerns
